Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial

Ähnliche Einträge

• Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
  von: Andrew Blumenfeld, et al.
  Veröffentlicht: (2024)
• Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
  von: Stephen D. Silberstein, et al.
  Veröffentlicht: (2024)
• A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
  von: Meesha Trivedi, et al.
  Veröffentlicht: (2024)
• The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
  von: Dani C. Smith, et al.
  Veröffentlicht: (2024)
• Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
  von: Chia‐Chun Chiang, et al.
  Veröffentlicht: (2024)